Intuitive Surgical Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.6% | -2.0% | +6.3% | +1.4% | +18.4% | -6.6% | +8.3% | +2.7% | +14.4% | -3.3% | +4.4% | – | |
| – | +12.9% | -0.9% | -1.2% | +4.2% | +16.1% | +3.2% | +3.3% | +2.5% | +14.1% | -2.2% | -0.9% | – | |
| – | +9.4% | -2.5% | +10.2% | +0.1% | +19.5% | -11.2% | +11.0% | +2.8% | +14.6% | -3.9% | +7.1% | – | |
| – | +4.3% | +9.4% | -1.5% | +2.1% | +3.0% | +7.3% | -0.9% | +5.1% | +7.1% | +2.6% | +2.4% | – | |
| – | +25.5% | -13.3% | +6.9% | -2.8% | +20.0% | -8.0% | -0.4% | +2.2% | +19.8% | -10.7% | +0.8% | – | |
| – | +17.9% | -6.2% | +3.8% | -1.1% | +13.9% | -3.1% | -0.6% | +3.2% | +15.2% | -6.2% | +1.4% | – | |
| – | -3.3% | +4.3% | +20.9% | +1.8% | +27.3% | -21.3% | +28.6% | +2.2% | +13.8% | -1.0% | +13.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.2% | +4.4% | +21.5% | +2.5% | +20.7% | -17.4% | +24.5% | +2.8% | +11.7% | -1.6% | +12.1% | – | |
| – | -192.8% | – | – | -18.4% | +21.3% | -128.9% | – | -13.0% | +6.9% | -26.7% | +102.3% | – | |
| – | +45.8% | -10.1% | -3.3% | +7.2% | +21.3% | +1.9% | -5.7% | +7.0% | +12.8% | +3.4% | -0.4% | – | |
| – | +1.3% | +1.4% | +18.3% | +2.7% | +18.7% | -13.4% | +22.0% | +2.8% | +15.9% | -3.1% | +3.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.